The Discounted Cash Flow (DCF) valuation of Hikma Pharmaceuticals PLC (HIK.L) is 1,782.08 GBP. With the latest stock price at 1,308.00 GBP, the upside of Hikma Pharmaceuticals PLC based on DCF is 36.2%.
Based on the latest price of 1,308.00 GBP and our DCF valuation, Hikma Pharmaceuticals PLC (HIK.L) is a buy. buying HIK.L stocks now will result in a potential gain of 36.2%.
| Range | Selected | |
| WACC / Discount Rate | 8.0% - 10.9% | 9.4% |
| Long-term Growth Rate | 0.0% - 1.0% | 0.5% |
| Fair Price | 1,427.41 - 2,331.84 | 1,782.08 |
| Upside | 9.1% - 78.3% | 36.2% |